Edwin Jonathan Tucker - 15 Feb 2024 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Chief Medical Officer
Signature
By: /s/ Ronald Martell, as Attorney-in-Fact
Issuer symbol
JSPR
Transactions as of
15 Feb 2024
Net transactions value
$0
Form type
4
Filing time
20 Feb 2024, 19:22:06 UTC
Previous filing
13 Jun 2023
Next filing
10 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Award $0 +45,000 $0.000000 45,000 15 Feb 2024 Voting Common Stock 45,000 $17.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on February 15, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.